×
Startup City Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Startup City
Weekly Brief
Weekly Brief
Thursday, March 19,2020
Feature of the Week
The digital universe has grown exponentially over the last few years and is expected to reach 44 trillion gigabytes this year. Read more ‣
To meet the needs of regular corporate clients, the company is eyeing a larger share of what CEO Jeff Grass sees as a $65 billion catering market
Read more ‣
The company intends to use the newly raised capital to digitize the next generation of brick-and-mortar retail and shopping centers on a global level
Read more ‣
Kymera Therapeutics is developing targeted protein degradation to invent breakthrough protein degrader medicines for patients.
Read more ‣
CIO Viewpoint
By Salumeh Companieh, CIO, C&W Services
Whatever your industry, chances are you have access to important data that could fundamentally change the way you do business. The trick is figuring out how to use it optimally.
Read more ‣
By Steven John, CIO, AmeriPride
Transforming IT Infrastructure to Enhance Customer Service.
Read more ‣
Featured Vendors
By George Wrenn, Founder & CEO
Provides a SaaS solution that enables continuous improvement of an organizations cybersecurity posture and manage an effective cyber strategy Read more ‣
By John Butler, Co-Founder & CEO
QuantumCyte is a biotech platform that works in the area of developing an effective cancer treatment. With a mission to make patient biopsies faster and more accurate, the company aims to gain precise results on drug therapy. The vision behind the... Read more ‣
By Yochi Slonim, Co-founder and CEO
Anima Biotech is advancing Translation Control Therapeutics, the first and only platform for the discovery of small molecule drugs that control mRNA translation as a new strategy against hard and undruggable targets in many diseases. Read more ‣
CXO Insights
By Ryan Wang, Co-Founder & General Partner, Outpost Capital
Given the ability of these inventions to redefine the perception of reality, it goes without saying... Read more ‣
By Ulrich Geilinger, Venture Capitalist, HBM Partners AG
One of the most profitable and but also very risky venture is the development of a new drug that... Read more ‣
